Metraipolis › archive › dc_a915599b3bba

Targeting Oxalate Production by Combining Enzyme Inhibition and Proteolysis Activation: A Novel Therapeutic Approach for Primary Hyperoxaluria Type 1 — Europe PMC PMID:41480893

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41480893
DOI
10.1021/acs.jmedchem.5c02055
License (as archived)
solo-consultazione
Archived
2026-11-07T03:12:15.881Z
SHA-256 of the archived text
e980eddd25496b08ef5858c49a361f68e60265a28d2df13ff3349af99b2ce333
Stable URL of this page
https://metraipolis.com/documento/dc_a915599b3bba

How to cite

Targeting Oxalate Production by Combining Enzyme Inhibition and Proteolysis Activation: A Novel Therapeutic Approach for Primary Hyperoxaluria Type 1 — Europe PMC PMID:41480893 — Europe PMC (en), https://europepmc.org/article/MED/41480893 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a915599b3bba (Metraipolis archive dc_a915599b3bba, sha256 e980eddd25496b08ef5858c49a361f68e60265a28d2df13ff3349af99b2ce333)
BibTeX
@misc{dca915599b3bba,
  title = {Targeting Oxalate Production by Combining Enzyme Inhibition and Proteolysis Activation: A Novel Therapeutic Approach for Primary Hyperoxaluria Type 1 — Europe PMC PMID:41480893},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41480893},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a915599b3bba; sha256 e980eddd25496b08ef5858c49a361f68e60265a28d2df13ff3349af99b2ce333},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41480893. Agents can read the archived copy with the MCP tool read_document.